Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype-Reference-Cited by-同舟云学术

Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

Published:2007-08-26 Issue:9 Volume:13 Page:1086-1095
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Podrez Eugene A,Byzova Tatiana V,Febbraio Maria,Salomon Robert G,Ma Yi,Valiyaveettil Manojkumar,Poliakov Eugenia,Sun Mingjiang,Finton Paula J,Curtis Brian R,Chen Juhua,Zhang Renliang,Silverstein Roy L,Hazen Stanley L

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1626.pdf

Reference45 articles.

1. Trip, M.D., Cats, V.M., van Capelle, F.J. & Vreeken, J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 322, 1549–1554 (1990).

2. Lacoste, L. et al. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 92, 3172–3177 (1995).

3. Kabbani, S.S. et al. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104, 181–186 (2001).

4. Vanschoonbeek, K. et al. Thrombin-induced hyperactivity of platelets of young stroke patients: involvement of thrombin receptors in the subject-dependent variability in Ca2+ signal generation. Thromb. Haemost. 88, 931–937 (2002).

5. Kabbani, S.S. et al. Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later. Am. J. Cardiol. 91, 876–878 (2003).

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD36: a promising therapeutic target in hematologic tumors;Leukemia & Lymphoma;2024-07-09

2. Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review);International Journal of Molecular Medicine;2024-05-10

3. Lipoprotein(a): an important consideration for DAPT therapy after PCI;Cardiology Journal;2024-04-26

4. Oxidized phospholipid-protein adducts: The future targets of interest;Archives of Biochemistry and Biophysics;2024-04

5. NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity;Redox Biology;2024-04